Preparation of newly identified polysaccharide fromPleurotus eryngiiand its anti-inflammation activities potential
Preparation of newly identified polysaccharide fromPleurotus eryngiiand its anti-inflammation activities potential
复制标题
DOI:
10.1111/1750-3841.15375
复制
发表时间:
2020-08-14
影响因子:
3.9
通讯作者:
Xiao, Hang
中科院分区:
文献类型:
--
作者:
Ma, Gaoxing;Kimatu, Benard Muinde;Xiao, Hang
The anti-inflammatory effects of two newly identifiedPleurotus eryngiipolysaccharides (WPEP, NPEP) were determined in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages in this study. Characterization analysis revealed that molecular weights of WPEP and NPEP were 167 and 274 kDa, and were mainly composed of glucose with beta-type glycosidic linkages. WPEP and NPEP could significantly inhibit LPS-induced inflammatory responses by regulating the production of NO, Protaglandin E2 (PGE(2)), Interleukin-1 beta (IL-1 beta), Tumor necrosis factor-alpha (TNF-alpha), and Interleukin-6 (IL-6). This was through the blocking of the activation of Mitogen-activated protein kinase (MAPK) pathway by inhibiting phosphorylation of p38, extracellular regulation of protein kinases 1/2, and stress-activated protein kinase/jun aminoterminal kinase. Moreover, WPEP and NPEP inhibited NF-kappa B signaling by reducing nuclear translocation and phosphorylation of p65. Overall, our results, for the first time identified twoP. eryngiipolysaccharides and demonstrated the related anti-inflammatory effects, which indicated the favorable potential ofP. eryngiipolysaccharide as specific functional foods. Practical Application This study prepared and characterized newly identifiedPleurotus eryngiiwater-soluble polysaccharide fractions and elucidated the nutritional benefits, mainly the immune response related to anti-inflammatory activities by utilizing lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Collectively, results of this study suggested that theP. eryngiipolysaccharide fractions could be considered as potential candidates for exploration in the development of new immunomodulatory agent or functional supplementary foods.